» Authors » Roberto Angioli

Roberto Angioli

Explore the profile of Roberto Angioli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 233
Citations 2871
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Luvero D, Angioli R, Notaro E, Plotti F, Terranova C, Angioli A, et al.
Diagnostics (Basel) . 2024 Nov; 14(22). PMID: 39594243
Background: Serous tubal intraepithelial carcinoma (STIC) is an early-stage cancerous lesion found in the fallopian tubes, often at the fimbrial end. It is strongly associated with high-grade serous carcinoma (HGSC),...
2.
Plotti F, Rampello S, Terranova C, De Cicco Nardone C, Luvero D, Montera R, et al.
J Clin Med . 2024 Aug; 13(16). PMID: 39200904
: Transobturator techniques are frequently used for the surgical treatment of female stress urinary incontinence (SUI), due to their high success rates and few intraoperative complications. However, controversial results have...
3.
Di Donato V, Giannini A, Galli V, Di Donna M, Congiu M, Garganese G, et al.
Int J Gynecol Cancer . 2024 Jul; 34(8):1133-1139. PMID: 39002981
Objective: To assess if the use of a V-Y reconstructive flap after excisional radical surgery positively influences the surgical outcomes in patients with vulvar cancer. Methods: This was a multicenter,...
4.
Faiella E, Pacella G, Vergantino E, Santucci D, De Cicco Nardone C, Terranova C, et al.
J Clin Med . 2024 Jul; 13(13). PMID: 38999385
: The aim of our study is to evaluate the feasibility and efficacy of the rendezvous technique for the treatment of iatrogenic ureteral injuries. : From 2014 to 2019, 29...
5.
Luvero D, Angioli R, Celoro F, Plotti F, Terranova C, Guzzo F, et al.
Pharmaceuticals (Basel) . 2024 Jun; 17(6). PMID: 38931448
Background: Ovarian cancer (OC) is a significant cause of cancer-related mortality in women globally, with a five-year survival rate of approximately 49%. Standard therapy involves cytoreductive surgery followed by chemotherapy....
6.
Luvero D, Silvagni A, Angioli A, Filippini M, Plotti F, Montera R, et al.
J Clin Med . 2024 Jun; 13(12). PMID: 38930079
: This multicentric prospective study was carried out at Fondazione Policlinico Universitario Campus Bio Medico and Ospedale di Stato of St. Marino Republic. Between 1 January 2019, and 31 December...
7.
Plotti F, Cundari G, Ficarola F, Terranova C, De Cicco Nardone C, Montera R, et al.
Healthcare (Basel) . 2024 Jun; 12(12). PMID: 38921303
The efficacy of hyaluronic acid instillations as therapy for patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) has been demonstrated in some clinical studies, with response rates up to 70%. The...
8.
Ragusa A, Ficarola F, Ferrari A, Spirito N, Ardovino M, Giraldi D, et al.
EClinicalMedicine . 2024 Jun; 73:102665. PMID: 38873634
Background: To assess the equivalence of tranexamic acid (TRAN) versus synthetic oxytocin (OXY) in reducing post-partum blood loss, in full-term patients (37-42 weeks), at low risk of post-partum hemorrhage, with...
9.
Luvero D, Cundari G, Ficarola F, Plotti F, Terranova C, Montera R, et al.
Cancers (Basel) . 2024 May; 16(10). PMID: 38791945
The Cancer Genome Atlas (TCGA) has radically changed the history of endometrial cancer by outlining a new classification, based on its molecular characteristics. In the field of oncology, we are...
10.
Perrone C, Angioli R, Luvero D, Giannini A, Di Donato V, Cuccu I, et al.
J Gynecol Oncol . 2024 May; 35(4):e104. PMID: 38768941
Mutations in genes encoding for proteins along the RAS-RAF-MEK-ERK pathway have been detected in a variety of tumor entities including ovarian carcinomas. In the recent years, several inhibitors of this...